Too old for major free flap reconstructive surgery in Head and Neck cancer management?

2019 ◽  
Vol 57 (10) ◽  
pp. e76-e77
Author(s):  
Mr Oliver Mitchell ◽  
Ms Grace Shaw ◽  
Mr Madan Ethunandan ◽  
Mr Sanjay Sharma ◽  
Mr Rabindra Singh
2010 ◽  
Vol 37 (2) ◽  
pp. 205-211 ◽  
Author(s):  
Seiichi Yoshimoto ◽  
Kazuyoshi Kawabata ◽  
Hiroki Mitani

2010 ◽  
Vol 37 (2) ◽  
pp. 212-216 ◽  
Author(s):  
Seiichi Yoshimoto ◽  
Kazuyoshi Kawabata ◽  
Hiroki Mitani

Head & Neck ◽  
2021 ◽  
Vol 43 (11) ◽  
pp. 3417-3428
Author(s):  
Peter Francis Gearing ◽  
John Frederick Daly ◽  
Nicholas Shi Jie Tang ◽  
Kasha Singh ◽  
Anand Ramakrishnan

2021 ◽  
Vol 11 (5) ◽  
pp. 393
Author(s):  
Francesca De Felice ◽  
Daniela Musio ◽  
Vincenzo Tombolini

In head and neck cancer management, there is a need for tailored approaches to optimally implement clinical outcomes. Based on the assumption that efficacy and long-term toxicity are not satisfactory for standard concurrent platinum-based chemoradiotherapy, several trials have been designed to test whether induction immunotherapy and/or concomitant immunotherapy and radiotherapy result in improved survival and toxicity outcomes. Here, we present an overview of the most recent concomitant therapeutic strategies for head and neck cancer, focusing on the knowledge available regarding check-point inhibitors. The aim is to present the characteristics of the main check-point inhibitors and to summarize the clinical trials on the combination of immune check-point inhibitors and (chemo)radiotherapy in the definitive HNC setting, in order to provide a useful clinical tool for further research.


2021 ◽  
pp. 030089162110079
Author(s):  
Marta Tagliabue ◽  
Beth Russell ◽  
Charlotte Moss ◽  
Rita De Berardinis ◽  
Francesco Chu ◽  
...  

Objective: To describe the approach and outcomes from two cancer centres in Southern and Northern Europe during the first wave of coronavirus disease 2019 (COVID-19) of patients with head and neck cancer (HNC). Methods: Data collection was performed on a retrospective cohort of patients surgically treated for primary HNC between March and May 2020, using data from two tertiary hospitals: the European Institute of Oncology (Milan) and Guy’s & St Thomas’ NHS Foundation Trust (London). Results: We included 77 patients with HNC. More patients with COVID-19 were taking angiotensin-converting enzyme (ACE) inhibitors and had Clavien-Dindo Classification grade I compared to negative patients, respectively (60% vs 22% [ p = 0.058] and 40% vs 8% [ p = 0.025]). Multivariate logistic regression analyses confirmed our data ( p = 0.05 and 0.03, respectively). Sex and age were statistically significantly different ( p = 0.05 and <0.001 respectively), showing more male patients (75% vs 53.66%, respectively) and more elderly patients in Italy than in the United Kingdom (patients aged >63 years: 69.44% vs 29.27%). Conclusions: This study presents a large cohort of patients with HNC with nasopharyngeal swab during the first peak of the COVID-19 pandemic in Europe. Patients with HNC with COVID-19 appeared more likely to develop postsurgical complications and to be taking ACE inhibitors. The preventive measures adopted guaranteed the continuation of therapeutic surgical intervention.


IDCases ◽  
2016 ◽  
Vol 3 ◽  
pp. 8-9
Author(s):  
Nishitha Shetty ◽  
Amit Joshi ◽  
Vanita Noronha ◽  
Sachin Dhumal ◽  
Sridhar Epari ◽  
...  

2018 ◽  
Vol 158 (2) ◽  
pp. 265-272 ◽  
Author(s):  
Antoine Eskander ◽  
Stephen Y. Kang ◽  
Benjamin Tweel ◽  
Jigar Sitapara ◽  
Matthew Old ◽  
...  

Objective To determine the predictors of length of stay (LOS), readmission within 30 days, and unplanned return to the operating room (OR) within 30 days in head and neck free flap patients. Study Design Case series with chart review. Setting Tertiary academic cancer hospital. Subjects and Methods All head and neck free flap patients at The Ohio State University (OSU, 2006-2012) were assessed. Multivariable logistic regression to assess the impact of patient factors, flap and wound factors, and intraoperative factors on the aforementioned quality metric outcomes. Results In total, 515 patients were identified, of whom 66% had oral cavity cancers, 33% had recurrent tumors, and 28% underwent primary radiotherapy. Of the patients, 31.5% had a LOS greater than 9 days, predicted by longer operative time, oral cavity and pharyngeal tumor sites, blood transfusion, diabetes mellitus, and any complication. A total of 12.6% of patients were readmitted within 30 days predicted by absent OSU preoperative assessment clinic attendance and any complication, and 14.8% of patients had an unplanned OR return predicted by advanced age. Conclusions When assessing quality metrics, adjustment for the complexity involved in managing patients with head and neck cancer with a high comorbidity index, clean contaminated wounds, and a high degree of primary radiotherapy is important. Patients seen in a preoperative assessment clinic had a lower risk of readmission postoperatively, and this should be recommended for all head and neck free flap patients. Quality improvement projects should focus on predictors and prevention of complications as this was the number one predictor of both increased length of stay and readmission.


2021 ◽  
Vol 62 (2) ◽  
Author(s):  
Ankita KAR ◽  
Nirmalendu SAHA ◽  
Asheem RAMIZ ◽  
Udayan BHAUMIK ◽  
Satish C

Sign in / Sign up

Export Citation Format

Share Document